For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Wellstat Therapeutics Corporation

USPTO Granted Patents = 62

% Expired Patents = 51.6

CIPO Patents = 2

EPO Patents = 18

Trademarks = 3

Forward Citations = 420

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Reid W Von Borstel (41 out of 89 patents)

Shalini Sharma (38 out of 41 patents)

Michael K Bamat (13 out of 34 patents)

4. Stephen D Wolpe (11 out of 16 patents)

5. Kirvin L Hodge (10 out of 12 patents)

6. James Dennen O'Neil (5 out of 5 patents)

7. Irena Tsyrlova (5 out of 9 patents)

8. Ramachandran Arudchandran (4 out of 4 patents)

9. Reid Warren Von Borstel (4 out of 14 patents)

10. Julian Reading (3 out of 4 patents)

11. Fedor Evgenievich Romantsev (3 out of 6 patents)

12. Bradley M Hiltbrand (3 out of 8 patents)

13. David M Simpson (2 out of 16 patents)

14. Dennis Bryan Zerby (2 out of 3 patents)

15. Ming Lu (2 out of 3 patents)

Core Competencies:

Aminoquinazoline Compounds

Benzoic Acid Compounds

Stem Cell Mobilization

Tetrazole Compounds

Mitochondrial Diseases

Acylated Nucleosides

Pyrimidine Nucleotide Precursors

Antimutagenic Compositions

Hematopoiesis

Wound Healing

Chemotherapeutic Agents

Inflammatory Hepatitis

62 patents: Sort by Forward Citations

1. 10934284 - Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity (2021-03-02),

2. 10085957 - Benzoic acid compounds for reducing uric acid (2018-10-02),

3. 10030015 - Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity (2018-07-24),

4. 9428552 - Stem cell mobilization and tissue repair and regeneration (2016-08-30),

5. 9133073 - Compounds for the treatment of metabolic disorders (2015-09-15),

6. 9115072 - Compounds and method for reducing uric acid (2015-08-25),

7. 8889724 - Tetrazole compounds for reducing uric acid (2014-11-18),

8. 8829058 - Compounds and method for reducing uric acid (2014-09-09),

9. 8703991 - Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids (2014-04-22),

10. 8664433 - Synthesis of 4-[3-(2,6-dimethylbenzyloxy)phenyl]-4-oxobutanoic acid (2014-03-04),

11. 8604083 - Method for the treatment of metabolic disorders (2013-12-10),

12. 8552062 - Methods for the treatment of metabolic disorders such as diabetes (2013-10-08),

13. 8546448 - 3-substituted compounds for reducing uric acid (2013-10-01),

14. 8481595 - Compounds for the treatment of metabolic disorders (2013-07-09),

15. 8410154 - Tetrazole compounds for reducing uric acid (2013-04-02),

Company Overview

Wellstat Therapeutics Corporation, based in Gaithersburg, MD, specializes in the development of innovative therapies for metabolic disorders. The company focuses on a range of core technologies, including aminoquinazoline and benzoic acid compounds, as well as advancements in stem cell mobilization and mitochondrial diseases. Wellstat's research encompasses acylated nucleosides and pyrimidine nucleotide precursors, aiming to address complex health challenges through cutting-edge scientific approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

62 Patents

#5 in Gaithersburg, MD

#56 in Maryland

#5,845 in US

#11,768 in the World

Gaithersburg, MD, United States of America

Wellstat Therapeutics Corporation

Forward Citations = 420

30 inventors:

Reid W Von Borstel (41 out of 89 patents)

Shalini Sharma (38 out of 41 patents)

Michael K Bamat (13 out of 34 patents)

4. Stephen D Wolpe (11 out of 16 patents)

5. Kirvin L Hodge (10 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Wellstat Therapeutics Corporation. Retrieved from https://idiyas.com/company/wellstat-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…